*Women's Health Medical Device Innovation Initiatives

Past New Requirement Updated

Agency
Solicitation expected
Estimated value
$3,000,000 to $7,000,000
Set-aside
No set-aside

Forecast facts

Anticipated award
NAICS code
Not on record
Points of contact

Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.

About this forecast

The Food and Drug Administration's Center for Devices and Radiological Health is procuring support to stimulate medical device innovation in women's health, specifically through Initiative 1 (Stimulating Medical Device Innovation in Maternal Health) and Initiative 2 (Menopause - The Modifiable Decades), with the solicitation estimated to release on October 1, 2026 and award expected by April 1, 2027. The work will equip CDRH with an evidence base and strategic roadmap to address critically underserved areas of women's health through medical device innovation.

The estimated award value ranges from $3 million to $7 million. Interested vendors should direct inquiries to the FDA's Center for Devices and Radiological Health acquisitions mailbox at cdhracquisitions@fda.hhs.gov.

Forecast text

Women's Health Medical Device Innovation InitiativesInitiative 1: Stimulating Medical Device Innovation in Maternal HealthInitiative 2: Menopause - The Modifiable Decadesto equip CDRH with evidence base and strategic roadmap needed to stimulate medical device innovation in critically underserved areas of women's health

On GovTribe

Work this forecast

  • Track it in your pipeline
  • Find teaming partners
  • Similar forecasts
  • Ask GovTribe AI about this forecast